Clinical Trial Update: Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing prednisone and tamoxifen for idiopathic retroperitoneal fibrosis is ongoing. The current trial status is not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Retroperitoneal Fibrosis

Drugs mentioned

• PREDNISONE (Prednisone)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: University of Parma | Conditions: Retroperitoneal Fibrosis | Phase 2 | Status: UNKNOWN